Background:
Persistent aldosterone-driven hypertension remains common despite established renin-angiotensin system blockade and mineralocorticoid receptor antagonism. Aldosterone synthase (CYP11B2) inhibition directly suppresses aldosterone biosynthesis, but its blood pressure (BP) effects across different agents an...
S. Ramadan, Amr M. Abou Elezz, Ahmed N. Mohamed et al.· Circulation· 0 citations
Low-density lipoprotein cholesterol (LDL-C) is the principal target for preventing atherosclerotic cardiovascular disease, yet many patients do not reach treatment goals with statins, and established proprotein convertase subtilisin/kexin type 9 (PCSK9) antibodies require injections every 2-4 weeks. Recaticimab is a hu...
Ahmed Talkhan, Amr M. Abou Elezz, N. Borham et al.· Cardiology in Review· 0 citations
Music is a safe, inexpensive adjunct that effectively reduces pain, anxiety, and heart rate during cystoscopy and may enhance patient comfort and procedural tolerance.
Mohamed Abo Zeid, Michael Gerges, Kareem Khalefa et al.· International Urogynecology...· 1 citation
Ongericimab is a humanized monoclonal antibody against proprotein convertase subtilisin/kexin type 9 that reduces LDL-C and increases apolipoprotein A1 and high-density lipoprotein cholesterol and increased apolipoprotein A1 and high-density lipoprotein cholesterol (all P < 0.0001).
Ahmed Talkhan, M. Elkasaby, Ahmed S. A. Osman et al.· Cardiology in Review· 0 citations
TNS improved urodynamic function in PD patients, but this objective improvement does not consistently translate to subjective symptom relief, highlighting the complexity of PD-related LUTS.
Mohamed F. Abo-elsoad, Ahmed W. Abbas, Amr M. Abou Elezz et al.· Acta Neurologica Belgica· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.